美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=PRILOSEC
符合检索条件的记录共6
1 页 当前第 1 页  返回检索页
1药品名称PRILOSEC
申请号019810产品号001
活性成分OMEPRAZOLE市场状态停止上市
剂型或给药途径CAPSULE, DELAYED REL PELLETS;ORAL规格20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1989/09/14申请机构ASTRAZENECA PHARMACEUTICALS LP
2药品名称PRILOSEC
申请号019810产品号002
活性成分OMEPRAZOLE市场状态停止上市
剂型或给药途径CAPSULE, DELAYED REL PELLETS;ORAL规格40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1998/01/15申请机构ASTRAZENECA PHARMACEUTICALS LP
3药品名称PRILOSEC
申请号019810产品号003
活性成分OMEPRAZOLE市场状态停止上市
剂型或给药途径CAPSULE, DELAYED REL PELLETS;ORAL规格10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/10/05申请机构ASTRAZENECA PHARMACEUTICALS LP
4药品名称PRILOSEC OTC
申请号021229产品号001
活性成分OMEPRAZOLE MAGNESIUM市场状态非处方药
剂型或给药途径TABLET, DELAYED RELEASE;ORAL规格EQ 20MG BASE
治疗等效代码参比药物
批准日期2003/06/20申请机构ASTRAZENECA PHARMACEUTICALS LP
5药品名称PRILOSEC
申请号022056产品号001
活性成分OMEPRAZOLE MAGNESIUM市场状态处方药
剂型或给药途径FOR SUSPENSION, DELAYED RELEASE;ORAL规格EQ 2.5MG BASE/PACKET
治疗等效代码参比药物
批准日期2008/03/20申请机构ASTRAZENECA PHARMACEUTICALS LP
6药品名称PRILOSEC
申请号022056产品号002
活性成分OMEPRAZOLE MAGNESIUM市场状态处方药
剂型或给药途径FOR SUSPENSION, DELAYED RELEASE;ORAL规格EQ 10MG BASE/PACKET
治疗等效代码参比药物
批准日期2008/03/20申请机构ASTRAZENECA PHARMACEUTICALS LP